Drug application
QUETIAPINE FUMARATE (QUETIAPINE FUMARATE)
Drugs@FDA ANDA 202228 · RISING
Key facts
| Drug name | QUETIAPINE FUMARATE |
|---|---|
| Active ingredients | QUETIAPINE FUMARATE |
| Application type | ANDA |
| Application number | 202228 |
| Company | RISING |
| Dosage forms | TABLET, EXTENDED RELEASE, ORAL |
| Strength | EQ 50MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Feb 2, 2021 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.